SHH and thyroid gland carcinoma: Importantly, our experiments demonstrate absence of Shh ligand in thyroid cancer cells with simultaneous constitutive activation of the pathway as shown by Gli transcriptional activity and sensitivity to cyclopamine treatment, suggesting that in thyroid cancer cells the Shh pathway is activated in a ligand-independent but Smo-dependent manner.